DuPont de Nemours Inc DD Unveils Ambitious 2035 Sustainability Goals Aligned With LongTerm Value Creation Yorkville MCGA Stock Retest Trade Unchanged 20260420 ASML Holding NV ASML Peer ASM Internationals BlownOut Q2 Guidance Reinforces Bullish Semiconductor Equipment Demand Thesis iShares MSCI France ETF EWQ Assessing Downside Risk Amid Escalating USEU Trade Brinkmanship Phillips 66 PSX Advances Western Gateway Pipeline Project Amid Positive Wall Street Price Target Revisions Generative AI Adoption Risks in Regulated Professional Services What could accelerate Rithm RPT stock growth Q4 2025 EPS Tops Views REE REE posts narrower Q4 2024 loss than expected but steep revenue drop sends shares 248 percent lower Western WEA Stock Should You Hold 028 20260420 Halliburton Company HAL Q1 2026 Earnings Surge on International Strength Offsetting Regional and Geopolitical Headwinds Market Wrap Tech outperforms consumer as major indexes dip First FMY Stock Buyback Program 021 20260420 Capital One Financial COF Valuation Assessment Following Recent YearToDate Share Price Pullback Alibaba Group Holding Limited BABA NearTerm Margin Pressures Overshadow LongTerm AI and Commerce Growth Upside VOYG Voyager Technologies tops Q4 2025 earnings estimates notching 154 year over year revenue growth and 232 intraday share gains TRON Tron management names Web3 ecosystem expansion its top strategic priority for upcoming fiscal quarters What JV transaction Odysightai ODYS Odysightai posts 1042 negative EPS surprise What interest rate risk AC Immune ACIU Investors Pile In 20260427 Entergy Corporation ETR Stock Weekly Analysis 016 20260422 Citigroup Inc C AI Sector Social and Operational Risk Analysis Following Targeted Executive Violence Incidents Energy Select Sector SPDR Fund XLE Rallies on Geopolitical Ceasefire Crude Inventory Tailwinds Is Repay RPAY stock overvalued today Repay posts 113 EPS miss amid mounting cost pressures John Wiley WLY Stock What Is Driving the Price Investor Concern 20260420 Bristol Myers Squibb BMY Emerges as the More Compelling LargeCap Biotech Pick vs Gilead Sciences